Skip to main content

International Journal of Clinical Oncology

Ausgabe 3/2024

Inhalt (13 Artikel)

Original Article

Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan

Koichi Yasuda, Yusuke Uchinami, Satoshi Kano, Jun Taguchi, Daisuke Kawakita, Megumi Kitayama, Kentaro Nishioka, Takashi Mori, Fuki Koizumi, Yuri Fujii, Yasushi Shimizu, Keiji Kobashi, Seiichi Yoshimoto, Ken-ichi Nibu, Akihiro Homma, Hidefumi Aoyama

Original Article

EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system

Kotaro Nomura, Keiju Aokage, Yasunori Kaminuma, Tokiko Nakai, Masashi Wakabayashi, Takashi Ikeno, Yutaro Koike, Tetsuro Taki, Tomohiro Miyoshi, Kenta Tane, Joji Samejima, Genichiro Ishii, Masahiro Tsuboi

Original Article

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

Hasan Çağrı Yıldırım, Yasin Kutlu, Emel Mutlu, Musa Barış Aykan, Mustafa Korkmaz, Selim Yalçın, Teoman Şakalar, Özde Melisa Celayir, Erkan Kayıkçıoğlu, Ferit Aslan, Emre Hafızoğlu, Yunus Emre Altıntaş, Merve Keskinkılıç, Elvin Chalabiyev, Abdussamet Çelebi, Bengü Dursun, Caner Kapar, Miraç Özen, Ömer Acar, Özgecan Dülgar, Engin Kut, Sedat Biter, Fatih Kus, Elvina Almuradova, Atike Pınar Erdoğan, Seray Saray, Deniz Can Güven, Eda Tanrıkulu Şimşek, Necdet Üskent, Yasemin Kemal, Burcu Çakar, Özgür Açıkgöz, Saadettin Kılıçkap, Sercan Aksoy

Original Article

Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer

Kazuhiro Nishikawa, Yutaka Kimura, Kentaro Kishi, Kentaro Inoue, Jin Matsuyama, Yusuke Akamaru, Shigeyuki Tamura, Junji Kawada, Tomono Kawase, Ryohei Kawabata, Yoshiyuki Fujiwara, Hitoshi Kanno, Takeshi Yamada, Toshio Shimokawa, Hiroshi Imamura

Original Article

Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer

Keigo Yokoi, Akiko Watanabe, Kazuko Yokota, Keita Kojima, Toshimichi Tanaka, Ken Kojo, Hirohisa Miura, Takahiro Yamanashi, Takeo Sato, Keishi Yamashita, Yusuke Kumamoto, Naoki Hiki, Takeshi Naitoh

Original Article

Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction

Tomoya Emori, Masahiro Itonaga, Reiko Ashida, Takashi Tamura, Yuki Kawaji, Keiichi Hatamaru, Yasunobu Yamashita, Kazuhiro Fukatsu, Toshio Shimokawa, Masataka Koike, Tetsuo Sonomura, Manabu Kawai, Masayuki Kitano

Open Access Original Article

Skeletal muscle status and survival among patients with advanced biliary tract cancer

Shinya Takaoka, Tsuyoshi Hamada, Naminatsu Takahara, Kei Saito, Go Endo, Ryunosuke Hakuta, Kota Ishida, Kazunaga Ishigaki, Sachiko Kanai, Kohei Kurihara, Hiroki Oyama, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Yukari Suzuki, Shuichi Tange, Yurie Tokito, Ryosuke Tateishi, Yousuke Nakai, Mitsuhiro Fujishiro

Open Access Original Article

Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice

Dag Rune Stormoen, Ulla Nordström Joensen, Gedske Daugaard, Peter Oturai, Emil Hyllested, Jakob Lauritsen, Helle Pappot

Original Article

The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan

Shuhei Suzuki, Yoshiyuki Nagumo, Shuya Kandori, Kousuke Kojo, Satoshi Nitta, Ichiro Chihara, Masanobu Shiga, Atsushi Ikeda, Takashi Kawahara, Akio Hoshi, Hiromitsu Negoro, Mathis J. Bryan, Ayako Okuyama, Takahiro Higashi, Hiroyuki Nishiyama

Original Article

Impact of prostate position-based image-guidance in intensity-modulated radiation therapy for localized prostate cancer

Rihito Aizawa, Haruo Inokuchi, Itaru Ikeda, Kiyonao Nakamura, Takashi Ogata, Shusuke Akamatsu, Takayuki Goto, Kimihiko Masui, Takayuki Sumiyoshi, Yuki Kita, Takashi Kobayashi, Takashi Mizowaki

Original Article

Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan

Nobuko Nakamura, Shinji Hasebe, Shintaro Yamanaka, Tomomi Fujii, Taketsugu Fujibuchi, Teruki Kitani, Kazuto Takeuchi, Yasushi Sato, Yoshitaro Shindo, Toshifumi Ozaki, Toshihiro Nishisho, Masahiro Tabata, Yoshihiro Yakushijin

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.